alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                                          5
<MULTIPLIER>                                       1
<CURRENCY>                                         U.S. DOLLARS
       
<S>                                                <C>
<PERIOD-TYPE>                                      3-MOS
<FISCAL-YEAR-END>                                  DEC-31-1999
<PERIOD-START>                                     JAN-01-1999
<PERIOD-END>                                       MAR-31-1999
<EXCHANGE-RATE>                                    1
<CASH>                                                 165,117
<SECURITIES>                                                 0
<RECEIVABLES>                                        1,889,584
<ALLOWANCES>                                          (302,679)
<INVENTORY>                                            338,919
<CURRENT-ASSETS>                                     3,556,720
<PP&E>                                                 976,900
<DEPRECIATION>                                        (543,150)
<TOTAL-ASSETS>                                       4,048,496
<CURRENT-LIABILITIES>                                2,194,839
<BONDS>                                                      0
<PREFERRED-MANDATORY>                                        0
<PREFERRED>                                                  0
<COMMON>                                                61,035
<OTHER-SE>                                             734,479
<TOTAL-LIABILITY-AND-EQUITY>                         4,048,496
<SALES>                                              1,510,597
<TOTAL-REVENUES>                                     1,510,597
<CGS>                                                1,181,397
<TOTAL-COSTS>                                        1,181,397
<OTHER-EXPENSES>                                       578,022
<LOSS-PROVISION>                                             0
<INTEREST-EXPENSE>                                      52,204
<INCOME-PRETAX>                                       (292,645)
<INCOME-TAX>                                                 0
<INCOME-CONTINUING>                                   (292,646)
<DISCONTINUED>                                               0
<EXTRAORDINARY>                                              0
<CHANGES>                                                    0
<NET-INCOME>                                          (292,646)
<EPS-PRIMARY>                                            (0.15)
<EPS-DILUTED>                                                0
        


</TABLE>
CATERPILLAR FINANCIAL SERVICES CORPORATION

POWERNOTES (SM)

With Maturities of 9 months or more from Date of Issue

 

Registration No.  333-97047

Filed Pursuant to Rule 424 (b) (3)

PRICING SUPPLEMENT NO.  234				Trade Date: 11/27/02
(To Prospectus Supplement dated August 15, 2002 & 

  Prospectus dated August 8,2002)					Issue Date:  12/03/02
The Date of this Pricing Supplement November 27, 2002
SUBJECT TO REDEMPTION OR REPAYMENT

  CUSIP									Date and terms of redemption or

     or	Stated				             Interest			repayment (including any

Common	Interest		  Price to	 Discounts &         Payment	Survivors		applicable regular or special

  Code	Rate (1)	Maturity	Public (2)	Commissions       Frequency	  Option	Yes/No	record dates)

14911QKT7  3.25%	12/15/06	     100%	        0.875%                Monthly	     YES	    NO	

Principal						1st Payment	Day	

Amount		Proceeds		Dealer		      Date		Count

$2,176,000.00	$2,156,960.00	ABN AMRO Inc.	   1/15/03		30/360	
 

Original Issue Discount Note:					Total Amount of OID:

____  Yes	  X   No						N/A

 

 
- The interest rates on the PowerNotes (SM) may be changed by Caterpillar Financial Services Corporation from time to time, but any such change will not affect the interest rate on any PowerNotes (SM) offered prior to the effective date of the change.   Prior to the date of this Pricing Supplement, $24.797 mm principal amount of the PowerNotes (SM) were sold at interest rates then in effect.  Subsequent offerings of PowerNotes (SM) will be made under the Prospectus Supplement and Prospectus dated August 8, 2002.
- Expressed as a percentage of aggregate principal amount.  Actual Price to Public may be less, and will be determined by prevailing market prices at the time of purchase as set forth in the confirmation sheet.
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pane l una ni m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l ar g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). NOT F OR P UB L I CAT I ON UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T UN I T E D S T AT E S OF AME R I C A, P l ai nt i ff

- A pp el l ee , v. J O E W I LLI E H O O K S, D e f

e n d an t - A p p e llan t. N o. 12- 10188 D. C . No . 2 : 9 6 - c r - 0 0 2 4 6 - R OS ME MOR AN DU M *

A pp ea l fr om the U ni t ed S t at es D i stri ctC ou rt

f orthe D i s tr i c tof

A r i z ona R os l y n O . S i l ve r , C hi e f Judge , P r e s i di ng S ubm i tt e d D e c e m be r19, 2012 ** B efo re: G O O D W IN , W A L L A C E , an dF IS H E R , C i rcu i tJu d g es. J oe W i l l i e H ooks appe a l s f r om the di s tr i c tc ourt ’ s or de rde ny i ng hi s 18 U . S . C . § 3 58 2(c) (2) m ot i on for r educt i on of se nt ence . W e have j uri sdi ct i on un der 2 8 U . S. C. § 1 2 9 1 , a n dw e a f f i rm. 

# FI LED DE C 31 2012 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALS12- 10188 2 H oo ks cont ends thathe i s e l i gi bl e f or a s ent ence re du ct i on un der A m e n d m e n t 7 5 0 to th e S e n te n c in g G u id e lin e s , w h ic h c h an g e dth e d ru g q u an tity t abl e i n U . S . S . G . § 2D 1. 1 f orof f e ns e s i nvol vi ng c r a c k c oc a i ne . T hi s c ont e nt i on f a i l s . A m e ndm e nt750 di d nota l t e rthe G ui de l i ne s r ange appl i c abl e t o the drug q u an tityu s e dto d e te rm in e H o o k s ’s s e n te n c e . See U .S .S .G . ap p . C , a m e n d . 7 5 0 . B ec ause A m endm ent75 0 d i d n otl ow erH oo ks’ s a dv i soryS ent enci ng G ui del i nes r an g e , th e d is tr ic t c o u rt la c k e dju r is d ic tio n to r e du c e h is s e n te n c e . See 1 8 U . S. C. § 3 5 8 2 ( c ) ( 2 ) ; U

ni te d States v . L e ni e ar , 57 4 F . 3d 66 8, 67 4 (9th C i r. 20 09 ). I n l i ghtof

thi s c onc l us i on, w e do notr e a c h H ooks ’ s c ont e nt i on tha tthe d is tr ic t c o u rt ab u s e dits d is c r e tio n b yf a ilin g to s ta te r e a s o n s f

o rd e n y in g h is m ot i on. AF F I RME D.
United States Court of Appeals

for the Fifth Circuit ____________

No. 22-10461

Summary Calendar

____________

United States of America, 

Plaintiff—Appellee,

versus

Hector Moises Andrade Ramirez, 

Defendant—Appellant.

______________________________

Appeal from the United States District Court 

for the Northern District of Texas

USDC No. 4:21-CR-286-1

______________________________

Before Stewart, Duncan, and Wilson, Circuit Judges.

Per Curiam:*

The Federal Public Defender appointed to represent Hector Moises 

Andrade Ramirez has moved for leave to withdraw and has filed a brief in 

accordance with Anders v. California, 386 U.S. 738 (1967), and United States 

v. Flores, 632 F.3d 229 (5th Cir. 2011). Ramirez has not filed a response. We 

have reviewed counsel’s brief and the relevant portions of the record 

_____________________

* This opinion is not designated for publication. See 5th Cir. R. 47.5.

United States Court of Appeals

Fifth Circuit

FILED

February 2, 2023

Lyle W. Cayce

Clerk

Case: 22-10461 Document: 00516633263 Page: 1 Date Filed: 02/02/2023
No. 22-10461

2

reflected therein. We concur with counsel’s assessment that the appeal 

presents no nonfrivolous issue for appellate review. Accordingly, counsel’s 

motion for leave to withdraw is GRANTED, counsel is excused from 

further responsibilities herein, and the appeal is DISMISSED. See 5th 

Cir. R. 42.2.

Case: 22-10461 Document: 00516633263 Page: 2 Date Filed: 02/02/2023
From: lucillewells2003@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 3:02:42 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Lucy Wells

Poulsbo, WA 98370
From: bo123engr@yahoo.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 2:42:26 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Robert Johnston

Chicago, IL 60647
**EXHIBIT 31.1**

 

SECTION 302 CERTIFICATION

 

I, Dean A. Ziehl, certifythat:

 

1. I have reviewed thisAnnual Report on Form 10-K of Adelphia Recovery Trust;

 

2. Based on my knowledge,this report does not contain any untrue statement of a material fact or omit tostate a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading withrespect to the period covered by this report;

 

3. Based on my knowledge,the financial statements, and other financial information included in thisreport, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, theperiods presented in this report;

 

4. The registrant’s other certifyingofficer and I are responsible for establishing and maintaining disclosurecontrols and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e))****for the registrant and have:

 

(a) Designed suchdisclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

 

(b) Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

 

(c) Disclosed in thisreport any changes in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect,****the registrant’s internal control over financial reporting;and

 

5. The registrant’s othercertifying officer and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s board of directors (or persons performingthe equivalent functions):

 

(a) All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

 

(b) Any fraud, whetheror not material, that involves management or other employees who have asignificant role in the registrant’s internal control over financial reporting.

 

Date: March 9, 2009

 
| /s/ Dean A. Ziehl |   |
|-------------------|--------|
|              |   |
| Dean A. Ziehl     |   |
|              |   |
| Trustee           |   |

 

----
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the annual Report of SunValley Solar, Inc. (the
“Company”) on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission
(the “Report”), We, James Zhang and Mandy Chung, Chief Executive Officer and Chief Financial
Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:



1.           
The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and



2.           
The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the
Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.



|By:    | /s/ James Zhang                        
|------ | ---------------------------------------
|Name:  | James Zhang                            
|Title: | Principal Executive Officerand Director
|Date:  | March 31, 2011                         
|       |                                        
|By:    | /s/ Mandy Chung                        
|       |                                        
|Name:  | Mandy Chung                            
|       |                                        
|Title: | Principal Financial Officer            
|       |                                        
|Date:  | March 31, 2010                         



This certification has been furnished solely pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
MATERIALS NOT INCLUDED IN

AIRWORTHINESS DIRECTIVE (AD) DOCKET

FAA-2012-0886

Docket Number

2008-SW-067-AD

Directorate Identifier

Name/Description of Item(s) Not Included in DMS Docket and Maintained in the 

Supplemental AD Docket

Agusta Bolletino Technico No. 139-126, dated June 20, 2008.

MAY BE VIEWED AT: Federal Aviation Administration

Office of the Regional Counsel,

Southwest Region

Rules Docket

2601 Meacham Blvd., Room 663

Fort Worth, Texas 76137

DURING THE HOURS OF: 9 a.m. and 3 p.m., Monday through Friday, except 

Federal holidays.
#### LINEAS AEREAS ALLEGRO S.A. DE C.V., a Mexican corporation, Plaintiff—Appellant, v. PEGASUS AVIATION INC, a California corporation; Pegasus Aviation I, a Delaware corporation; Pegasus Aviation IV, a Delaware corporation; Pegasus Aviation V, a Delaware corporation; Pegasus Aviation Lease Securitization, a Delaware corporation; Pacific Aircorp 49877, a Delaware corporation; Pacific Aircorp 49904, a Delaware corporation; Pacific Aircorp 49741, a Delaware corporation; Airline Partner Services, Inc., a Florida corporation, Defendants—Appellees.

No. 04-15224.

United States Court of Appeals, Ninth Circuit.

Argued and Submitted June 15, 2005.

Decided Aug. 12, 2005.

Molly Steele, Esq., Thompson *&*Knight, Dallas, TX, Dan W. Goldfine, Esq., Snell & Wilmer, LLP, Phoenix, AZ, for Plaintiff-Appellant.

George L. Paul, Esq., Susan M. Freeman, Esq., Doyle S. Byers, Esq., Lewis & Roca, LLP, Phoenix, AZ, for DefendantsAppellees.

Before: REAVLEY,* T.G. NELSON, and RAWLINSON, Circuit Judges.

*

 The Honorable Thomas M. Reavley, Senior United States Circuit Judge for the Fifth Circuit, sitting by designation.

*645MEMORANDUM **

Lineas Aéreas Allegro, S.A. de C.V. (“Allegro”) appeals on jurisdictional grounds the district court’s order granting Pegasus Aviation Inc.’s (“Pegasus”) motion to clarify two previous contempt orders. We have jurisdiction under 28 U.S.C. § 1291, and we affirm. Because the parties are familiar with the facts, we do not recount them here.

Pegasus’s motion sought only clarification of the court’s previous order; it did not seek to amend the orders. Thus, under Federal Rule of Civil Procedure 60(a), Pegasus timely filed its motion.1 The clarifying order did not address issues that were pending on appeal.2 Moreover, under Federal Rule of Civil Procedure 60(a), a district court retains jurisdiction to clarify an order.3 Accordingly, we affirm.

AFFIRMED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.

1

. *See Feb.*R. Civ. P. 60(a). We review the issue of whether a district court had subject matter jurisdiction de novo. *Morris v. Morgan Stanley & Co.,*942 F.2d 648, 650 (9th Cir.1991).

2

. *See Stein v. Wood, 127*F.3d 1187, 1189 (9th Cir.1997) (“As a general rule, the filing of a notice of appeal divests a district court of jurisdiction over those aspects of the case involved in the appeal.”).

3

. *Id.; Morris,*942 F.2d at 654; Fed R. Civ. P. 60(a).
[Federal Register Volume 88, Number 186 (Wednesday, September 27, 2023)]
[Notices]
[Page 66415]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-20919]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Patent and Trademark Office

[Docket No.: PTO-C-2023-0034]


Joint ITA-NIST-USPTO Collaboration Initiative Regarding Standards

AGENCY: United States Patent and Trademark Office, Department of 
Commerce.

ACTION: Request for comments; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office (USPTO) is 
extending the deadline for written comments announced in the Federal 
Register Notice titled ``Joint ITA-NIST-USPTO Collaboration Initiative 
Regarding Standards; Notice of Public Listening Session and Request for 
Comments.'' Through this notice, the USPTO is extending the period for 
public comments until November 6, 2023.

DATES: Written comments must be received on or before November 6, 2023.

FOR FURTHER INFORMATION CONTACT: Mr. Chris Hannon, at 571-272-7385 or 
Mr. Anthony Quinn, at 202-893-6488. Inquiries can also be sent to 
<a href="/cdn-cgi/l/email-protection#6f3c2a3f303f0003060c162f1a1c1f1b0041080019"><span class="__cf_email__" data-cfemail="b9eafce9e6e9d6d5d0dac0f9cccac9cdd697ded6cf">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: On September 11, 2023, the USPTO published a 
Federal Register Notice titled ``Joint ITA-NIST-USPTO Collaboration 
Initiative Regarding Standards; Notice of Public Listening Session and 
Request for Comments'' (88 FR 62349), announcing that the USPTO, the 
International Trade Administration (ITA), and the National Institute 
for Standards and Technology (NIST) are seeking stakeholder input on 
the current state of U.S. firm participation in standard setting, and 
the ability of U.S. industry to readily adopt standards to grow and 
compete, especially as they relate to the standardization of critical 
and emerging technologies. The Agencies are now extending the comment 
submission period until November 6, 2023, to ensure that stakeholders 
have a sufficient opportunity to submit written comments.
    All other information provided in the September 11, 2023, notice 
remains unchanged. Previously submitted comments do not need to be 
resubmitted.

Katherine K. Vidal,
Under Secretary of Commerce for Intellectual Property and Director of 
the United States Patent and Trademark Office.
[FR Doc. 2023-20919 Filed 9-26-23; 8:45 am]
BILLING CODE 3510-16-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>